Patent classifications
A61B2090/3933
INTRADURAL NEURAL ELECTRODES
Described herein are systems and methods for deploying and recording electrophysiologic signals from electrode arrays located within the dura mater of the brain. The dura matter includes layers of connective tissue, or membrane, that surround the brain and spinal cord. The present disclosure relates to an endovascular electrode system deployed within the blood vessels located between layers of the dura mater, including, for example, the middle meningeal artery and its branches.
Pixel array medical systems, devices and methods
Systems, instruments, and methods for minimally invasive procedures including one or more of fractional resection, fractional lipectomy, fractional skin grafting, and/or fractional scar revision are described. Embodiments include instrumentation comprising a scalpet assembly coupled to a carrier, and the scalpet assembly includes a scalpet array. The scalpet array includes one or more scalpets configured for fractional resection, fractional lipectomy, fractional skin grafting, and/or fractional scar revision. The system includes a vacuum component coupled to the scalpet assembly and configured to evacuate tissue from the a site. The carrier is configured to control application of a rotational force and/or a vacuum force to the scalpet assembly.
Transperineal prostate biopsy device, systems, and methods of use
A transperineal biopsy guide including a guide member and a displacement member supported by the guide member. The guide member may be configured to operably couple with the transrectal probe and may include a distal end, a proximal end opposite the distal end, and a length extending along a longitudinal axis between the distal and proximal ends. The displacement member may be configured to support the access needle and displace the access needle along at least a portion of the length of the guide member between the distal and proximal ends. The access needle may extend into the subcutaneous tissue when the access needle is displaced to the distal end.
Transperineal prostate biopsy device, systems, and methods of use
A biopsy guide for use in guiding a needle in a transperineal prostate biopsy procedure. The biopsy guide may include a guide member and a displacement member. The guide member may operably couple with the transrectal probe and include a guide body including a distal end, a proximal end, a length, a first guide member extending the length, and a second guide member extending the length, wherein a portion of the first and second guide members overhangs the transrectal probe when coupled thereto. The displacement member may be supported by the guide member and may include a central vertically extending member having a plurality of needle receiving ports therein, and a planar member coupled to the central vertically extending member and having a planar bottom surface that is configured to slide on the first and second planar top surfaces of the first and second guide members, respectively.
Transperineal prostate biopsy device, systems, and methods of use
A method of performing a transperineal biopsy procedure including sliding a displacement member of a biopsy guide relative to a guide member of the biopsy guide such that the displacement member is proximate the perineal access site of the patient. The guide member may be secured to the ultrasound probe, and the guide member may include a pair of guide rails each having a planar top surface. The displacement member may include a platform having a planar bottom surface and at least one needle receiving port for guiding a needle, wherein the planar bottom surface of the platform opposes the planar top surfaces of the pair of guide rails during the sliding of the displacement member relative to the guide member. The method may further include inserting a needle into the perineal access site of the patient.
DEVICES AND METHODS FOR EXCLUDING THE LEFT ATRIAL APPENDAGE
Systems, devices and methods for occluding the left atrial appendage (LAA). The device excludes the LAA from blood flow. The implantable device is delivered via transcatheter delivery into the LAA and secured within the LAA. The implant comprises an expandable and compliant frame and an expandable and conformable tubular foam body. A delivery and tether retraction system includes a handle for controlling a pusher and tether. The pusher may be moved a distance away from the implant without changing the orientation of the implant, while the tether is still attached to the implant. Severing the tether and proximally retracting a control on the hand piece by a distance causes the severed end to advance distally by at least about twice that distance. A loader includes a conical portion with guides and a reservoir for submerging the foam prior to loading and delivery.
DEVICES AND METHODS FOR EXCLUDING THE LEFT ATRIAL APPENDAGE
Systems, devices and methods for occluding the left atrial appendage (LAA). The device excludes the LAA from blood flow. The implantable device is delivered via transcatheter delivery into the LAA and secured within the LAA. The implant comprises an expandable and compliant frame and an expandable and conformable tubular foam body. A delivery and tether retraction system includes a handle for controlling a pusher and tether. The pusher may be moved a distance away from the implant without changing the orientation of the implant, while the tether is still attached to the implant. Severing the tether and proximally retracting a control on the hand piece by a distance causes the severed end to advance distally by at least about twice that distance. A loader includes a conical portion with guides and a reservoir for submerging the foam prior to loading and delivery.
DEVICES AND METHODS FOR EXCLUDING THE LEFT ATRIAL APPENDAGE
Systems, devices and methods for occluding the left atrial appendage (LAA). The device excludes the LAA from blood flow. The implantable device is delivered via transcatheter delivery into the LAA and secured within the LAA. The implant comprises an expandable and compliant frame and an expandable and conformable tubular foam body. A delivery and tether retraction system includes a handle for controlling a pusher and tether. The pusher may be moved a distance away from the implant without changing the orientation of the implant, while the tether is still attached to the implant. Severing the tether and proximally retracting a control on the hand piece by a distance causes the severed end to advance distally by at least about twice that distance. A loader includes a conical portion with guides and a reservoir for submerging the foam prior to loading and delivery.
Devices and methods for excluding the left atrial appendage
Systems, devices and methods for occluding the left atrial appendage (LAA). The device excludes the LAA from blood flow. The implantable device is delivered via transcatheter delivery into the LAA and secured within the LAA. The implant comprises an expandable and compliant frame and an expandable and conformable tubular foam body. A delivery and tether retraction system includes a handle for controlling a pusher and tether. The pusher may be moved a distance away from the implant without changing the orientation of the implant, while the tether is still attached to the implant. Severing the tether and proximally retracting a control on the hand piece by a distance causes the severed end to advance distally by at least about twice that distance. A loader includes a conical portion with guides and a reservoir for submerging the foam prior to loading and delivery.
Method and System for Improving Location Accuracy of a Radiofrequency Ablation Procedure Via Fiducial Marking
In accordance with one embodiment of the present invention, a method for improving location accuracy of a radiofrequency ablation procedure performed on a patient is contemplated. The method includes identifying a target nerve to be ablated, wherein the nerve is suspected of being a source of pain; delivering a pharmacological agent to the nerve to temporarily block nerve signal transmission along the nerve; verifying the nerve is the source of pain if the temporary block reduces a level of pain experienced by the patient; placing a fiducial marker adjacent the nerve if it is verified that the temporary block reduces the level of pain experienced by the patient; locating the fiducial marker; and delivering radiofrequency energy to an area of tissue adjacent the fiducial marker via a probe. The area of tissue corresponds with the nerve, and the radiofrequency energy is applied at a level sufficient to ablate the nerve.